|
Records 1-5 (of 5 Records) |
| Query Trace: IFNA2[original query]>>IFNA2[Gene] |
|---|
| Differentially expressed immune response genes in COVID-19 patients based on disease severity. Li Shasha, et al. Aging 2021 3 0. 
|
| Type-I Interferon assessment in 45 minutes using the FilmArray PCR platform in SARS-CoV-2 and other viral infections. Mommert Marine, et al. European journal of immunology 2020 12 0. 
|
| JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Stebbing Justin, et al. Science advances 2020 11 0.
|
| Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience. Pereda Ricardo, et al. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2020 9 0. (9) 438-442
|
| Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2. Yao Zhixian, et al. Aging 2020 5 0.
|
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 01, 2023
- Content source: